Search With Term
Recent Industry Update
- Case Insight – Torrent Pharma to acquire dermatology company Curatio Health Care
- Pfizer to acquire Biohaven Pharma for $11.6 billion
- EMA recommendation for 2022-2023 seasonal flu vaccine composition
- Aurobindo Pharma acquires Veritaz Healthcare
- Sun Pharma to launch Vortioxetine in India
- what is meaning of clinically significant endpoint?
- US FDA grants Breakthrough Therapy Designation for Pfizer’s RSVpreF
- Is HEOR and Market Access is same?
- Symbicort 1st generic Approval by USFDA
- Case Study : Vimpat patent expired on 17th of March, 2022 and generic entry
- Case Study : US FDA approval of Marinus Pharma’s Ztalmy
- Lynk Pharma, Simcere licensing deal for development of novel JAK1 inhibitor LNK01001 in China
- What if Design of experiments (DoE) approach?
- Torrent Pharma to manufacture and sell Pfizer’s Paxlovid generic
- What are the application of IVIVC?
- What is the meaning of IVIVC?
- Insight on AstraZeneca’s global R&D Postdoctoral Challenge initiative
- Medtronic launched MiniMed 780G system to manage type 1 diabetes
- Case Study: Pfizer’s Arena acquisition – A $6.7B deal
- Market Access – Check your competency
- Zydus gets orphan drug designation from USFDA for antimalarial compound
- Keros Therapeutics Strategic deal with Hansoh Pharma for Rights to KER-050 in China
- Case Study: Acquisition of Otrexup – A Drug Device Combination
- Case Insight: Natco acquires Dash Pharmaceuticals
- Cadila launches ayurvedic energy tonic Healtherbs
- Cipla’s social initiative to improve access to nebulisers in primary healthcare centres of rural India
- Aqilion buys rights to Phase-I ready anti-inflammatory program from LEO Pharma
- SPARC entered into a licensing agreement with Biomodifying
- AbbVie’s Skyrizifor received EC approval to treat adults with active psoriatic arthritis
- Insight on licensing deal of Pfizer and The Medicines Patent Pool for COVID-19 Oral Antiviral Treatment Candidate to Expand market Access in Low- and Middle-Income Countries
Monthly Archieves
- September 2022 (1)
- May 2022 (1)
- March 2022 (16)
- December 2021 (10)
- November 2021 (2)
- October 2021 (2)
- September 2021 (5)
- July 2021 (10)
- June 2021 (12)
- May 2021 (5)
- April 2021 (1)
- February 2021 (6)
- January 2021 (4)
- December 2020 (10)
- November 2020 (8)
- October 2020 (9)
- September 2020 (10)
- August 2020 (7)
- July 2020 (7)
- June 2020 (4)
- May 2020 (8)
- April 2020 (10)
- March 2020 (16)
- February 2020 (12)
- January 2020 (9)
- December 2019 (10)
- November 2019 (10)
- October 2019 (14)
- September 2019 (21)
- August 2019 (7)
- July 2019 (14)
- June 2019 (15)
- May 2019 (18)
- April 2019 (13)
- March 2019 (16)
- February 2019 (14)
- January 2019 (12)
- December 2018 (10)
- November 2018 (19)
- October 2018 (7)
- September 2018 (4)
- August 2018 (14)
- July 2018 (34)
- June 2018 (2)
- May 2018 (14)
- April 2018 (8)
- March 2018 (7)
- February 2018 (6)
- January 2018 (6)
- December 2017 (9)
- November 2017 (9)
- October 2017 (14)
- September 2017 (12)
- August 2017 (12)
- July 2017 (11)
- June 2017 (12)
- May 2017 (18)
- April 2017 (11)
- March 2017 (20)
- February 2017 (15)
- January 2017 (12)
- December 2016 (23)
- November 2016 (20)
- October 2016 (7)
- September 2016 (15)
- August 2016 (21)
- July 2016 (36)
- June 2016 (20)
- May 2016 (24)
- April 2016 (21)
- March 2016 (27)
- February 2016 (24)
- January 2016 (19)
- December 2015 (8)
- November 2015 (16)
- October 2015 (25)
- September 2015 (22)
- August 2015 (12)
- July 2015 (32)
- June 2015 (33)
- May 2015 (32)
- April 2015 (19)
- March 2015 (10)
- February 2015 (17)
- January 2015 (33)
- December 2014 (41)
- November 2014 (20)
- October 2014 (10)
- September 2014 (10)